Unknown

Dataset Information

A novel pathway of cellular activation mediated by antiphospholipid antibody-induced extracellular vesicles.


ABSTRACT:

Background

Elevated levels of endothelial cell (EC)-derived extracellular vesicles (EVs) circulate in patients with antiphospholipid antibodies (APLAs), and APLAs, particularly those against β2 -glycoprotein I (β2 GPI), stimulate EV release from ECs. However, the effects of EC-derived EVs have not been characterized.

Objective

To determine the mechanism by which EVs released from ECs by anti-β2 GPI antibodies activate unstimulated ECs.

Patients/methods

We used interleukin (IL)-1 receptor inhibitors, small interfering RNA (siRNA) against Toll-like receptors (TLRs) and microRNA (miRNA) profiling to assess the mechanism(s) by which EVs released from ECs exposed to anti-β2 GPI antibodies activated unstimulated ECs.

Results and conclusions

Anti-β2 GPI antibodies cau

SUBMITTER: Wu M 

PROVIDER: S-EPMC4877623 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature